U.S. Department of Health and Human Services
Andrew Bremer
 

 Contact Info

 
Tel: 301-402-7886
Email: andrew.bremer@nih.gov
 

 Select Experience

 
  • Associate ProfessorMedicine and Pediatrics, Vanderbilt University2010-2013
  • Clinical FellowPediatric Endocrinology, University of California, San Francisco2005-2007
  • ResidencyInternal Medicine / Pediatrics, Baylor College of Medicine2001-2005
  • M.A.S.Clinical Research, University of California, Davis2007-2009
  • M.D., Ph.D.Boston University2001

Andrew Bremer, M.D., Ph.D.

Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases

Current Responsibilities and Activities

My portfolio includes the management of basic science and clinical intervention projects focused on the prevention and treatment of type 2 diabetes.  In addition, I am the Project Scientist and/or Program Official on large NIDDK-supported multi-center type 2 diabetes-related clinical trials.

​Research Programs

Clinical Research in Type 2 Diabetes
This program supports studies in humans aimed at the prevention, treatment, and diagnosis of type 2 diabetes across the lifespan, as well as further characterizing and understanding the mechanistic aspects of the etiology of type 2 diabetes

Diabetes and Metabolism HIV/AIDS
The Diabetes and Metabolism HIV/AIDS program supports studies on the metabolic complications of HIV infection and treatment, including endocrine and body composition abnormalities

Diabetes: Treatment, Prevention, and Complications
This program supports both basic and clinical studies aimed at addressing the prevention, treatment, and pathophysiology of type 1 and type 2 diabetes

Pathophysiology of Diabetes and Metabolic Disease
This program supports basic and clinical research that addresses the pathophysiology of metabolic diseases, including the etiology of type 1 diabetes and other autoimmune endocrine diseases

Current Committee Memberships

  • NIDDK Clinical Studies Working GroupMember
  • NIDDK Obesity Working GroupMember